Showing results (71-80 of 656) with videos related to

Sort By:
Pageof 66
Scandinavian Journal of Gastroenterology|August 15, 2014
Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease CohortPhilippe Hiroz, Stephan R Vavricka, Nicolas Fournier, et al.
European Journal of Gastroenterology & Hepatology|November 29, 2013
Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn's diseaseMichael Scharl, Pascal Frei, Sandra M Frei, et al.
Digestive Diseases (Basel, Switzerland)|November 20, 2025
Clinical Utility of Intestinal Ultrasound for Guiding Therapy in Inflammatory Bowel Disease: A Retrospective Real-World Cohort from a Swiss Tertiary CenterNiki Jud, Luc Biedermann, Andrea S Kreienbuehl, et al.
Digestion|April 27, 2026
IL-22 associates with Venous Thromboembolism in Inflammatory Bowel Disease: A Hypothesis-Generating StudyRahel Cola, Gerhard Rogler, Luc Biedermann, et al.
Digestion|October 12, 2012
Mucosal healing with anti-TNF antibodiesJean-Baptiste Chevaux, Stephan R Vavricka, Gerhard Rogler, et al.
Digestion|August 18, 2015
Serum REG3alpha and C-Reactive Protein Levels in Crohn's Disease Patients Undergoing Immunoablation and Autologous Hemopoetic Stem Cell Transplantation in the ASTIC TrialThomas Greuter, Silvia Lang, Ernst Holler, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Fatigue in inflammatory bowel disease and its impact on daily activitiesPhilipp Schreiner, Jean-Benoît Rossel, Luc Biedermann, et al.
Digestive Diseases (Basel, Switzerland)|June 9, 2017
Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III SurveyStephan R Vavricka, Milos Spasojevic, Gerhard Rogler, et al.
United European Gastroenterology Journal|April 19, 2016
Risk factors for complications in patients with ulcerative colitisChristine N Manser, Jan Borovicka, Frank Seibold, et al.
Journal of Crohn'S & Colitis|August 14, 2012
Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - an open pilot studyLuc Biedermann, Jessica Mwinyi, Michael Scharl, et al.
Pageof 66